Florence K. Keane

A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis

Trupti Paranjape, Helen Heneghan, Robert Lindner et al. · The Lancet Oncology · 2011 · 133 citations

Genetic Analysis, Breast Oncology, Oncology +10

Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy

William L. Hwang, Andrzej Niemierko, Katie L. Hwang et al. · JAMA Oncology · 2017 · 98 citations · Full text

Metastatic Lung Cancer, Oncology, Advanced Lung Disease +9

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

Elena Ratner, Florence K. Keane, Robert Lindner et al. · Oncogene · 2011 · 82 citations · Full text

Medicine, Kras Variant, Pathology +11

Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era

Florence K. Keane, Yu‐Hui Chen, Bridget A. Neville et al. · Cancer · 2015 · 61 citations · Full text

The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate‐risk disease

Florence K. Keane, Ming‐Hui Chen, Danjie Zhang et al. · Cancer · 2014 · 50 citations · Full text